Skip to main content
Premium Trial:

Request an Annual Quote

Caprion Will Use CellCarta to Help Vertex Pharma Discover Biomarkers

NEW YORK, March 29 (GenomeWeb News) - Vertex Pharmaceuticals will rely on data from Caprion Pharmaceuticals' CellCarta proteomics platform as part of a biomarker-discovery collaboration, the company said today.

 

As part of the deal, Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and pre-clinical studies conducted by Vertex.

 

Caprion's platform profiles proteins and provides protein expression and identification in tissues and blood plasma.

 

Financial terms of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.